Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Gastrointestinal 1Classical hematology 1

Conditions

Fanconi Anemia 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Lymphoma, Non-Hodgkin 1Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

Fluorouracil 26Radiotherapy 17Mitomycin 17Cisplatin 12Capecitabine 12pembrolizumab 10Cyclophosphamide 9Radiation 8Paclitaxel 8fludarabine 7Specimen Handling 7Nivolumab 7Carboplatin 7Magnetic Resonance Spectroscopy 6Cetuximab 6Biopsy 6Papillomavirus Vaccines 5Drug Therapy 5dehydroftorafur 4aldesleukin 4Vaccines 4Radiotherapy, Intensity-Modulated 4Irinotecan 4Watchful Waiting 3Taxes 3Oxaliplatin 3Observation 3Light Coagulation 3Ipilimumab 3Interleukin-2 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Anus Neoplasms × SRA737 × Clear all
NCT02797964 2023-06-18

A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer

Sierra Oncology LLC - a GSK company

Phase 1/2 Completed
107 enrolled 20 charts
Classical hematologyGastrointestinalHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Fanconi Anemia, Lymphoma, Non-Hodgkin, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡